Home Applications 204569 Application 204569
Type NDA
Sponsor MERCK SHARP DOHME Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 BELSOMRA SUVOREXANT TABLET;ORAL 5MG Yes No 002 BELSOMRA SUVOREXANT TABLET;ORAL 10MG Yes No 003 BELSOMRA SUVOREXANT TABLET;ORAL 15MG Yes No 004 BELSOMRA SUVOREXANT TABLET;ORAL 20MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N204569-001 BELSOMRA SUVOREXANT 5MG TABLET / ORAL RLD 2014-08-13 N204569-002 BELSOMRA SUVOREXANT 10MG TABLET / ORAL RLD 2014-08-13 N204569-003 BELSOMRA SUVOREXANT 15MG TABLET / ORAL RLD 2014-08-13 N204569-004 BELSOMRA SUVOREXANT 20MG TABLET / ORAL RLD, RS 2014-08-13
Orange Book patents# Current patent rows page 1 of 1 · 16 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N204569-001 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 N204569-001 10098892 2033-05-29 Drug product 2018-10-17 N204569-001 11980623 2033-05-29 Drug product 2024-05-20 N204569-001 12599610 2033-05-29 Drug product 2026-06-17 N204569-002 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 N204569-002 10098892 2033-05-29 Drug product 2018-10-17 N204569-002 11980623 2033-05-29 Drug product 2024-05-20 N204569-002 12599610 2033-05-29 Drug product 2026-06-17 N204569-003 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 N204569-003 10098892 2033-05-29 Drug product 2018-10-17 N204569-003 11980623 2033-05-29 Drug product 2024-05-20 N204569-003 12599610 2033-05-29 Drug product 2026-06-17 N204569-004 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 N204569-004 10098892 2033-05-29 Drug product 2018-10-17 N204569-004 11980623 2033-05-29 Drug product 2024-05-20 N204569-004 12599610 2033-05-29 Drug product 2026-06-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N204569-001 BELSOMRA 5MG TABLET / ORAL RLD 2014-08-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-002 BELSOMRA 10MG TABLET / ORAL RLD 2014-08-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-003 BELSOMRA 15MG TABLET / ORAL RLD 2014-08-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-004 BELSOMRA 20MG TABLET / ORAL RLD, RS 2014-08-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-001 BELSOMRA 5MG TABLET / ORAL RLD 2014-08-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-002 BELSOMRA 10MG TABLET / ORAL RLD 2014-08-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-003 BELSOMRA 15MG TABLET / ORAL RLD 2014-08-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-004 BELSOMRA 20MG TABLET / ORAL RLD, RS 2014-08-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N204569-001 BELSOMRA 5MG TABLET / ORAL RLD 2014-08-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-002 BELSOMRA 10MG TABLET / ORAL RLD 2014-08-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-003 BELSOMRA 15MG TABLET / ORAL RLD 2014-08-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-004 BELSOMRA 20MG TABLET / ORAL RLD, RS 2014-08-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204569-001 BELSOMRA 5MG TABLET / ORAL RLD 2014-08-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204569-002 BELSOMRA 10MG TABLET / ORAL RLD 2014-08-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204569-003 BELSOMRA 15MG TABLET / ORAL RLD 2014-08-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204569-004 BELSOMRA 20MG TABLET / ORAL RLD, RS 2014-08-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204569-001 BELSOMRA 5MG TABLET / ORAL RLD 2014-08-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204569-002 BELSOMRA 10MG TABLET / ORAL RLD 2014-08-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204569-003 BELSOMRA 15MG TABLET / ORAL RLD 2014-08-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204569-004 BELSOMRA 20MG TABLET / ORAL RLD, RS 2014-08-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204569-001 BELSOMRA 5MG TABLET / ORAL RLD 2014-08-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204569-002 BELSOMRA 10MG TABLET / ORAL RLD 2014-08-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204569-003 BELSOMRA 15MG TABLET / ORAL RLD 2014-08-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204569-004 BELSOMRA 20MG TABLET / ORAL RLD, RS 2014-08-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204569-001 BELSOMRA 5MG TABLET / ORAL RLD 2014-08-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204569-002 BELSOMRA 10MG TABLET / ORAL RLD 2014-08-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204569-003 BELSOMRA 15MG TABLET / ORAL RLD 2014-08-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204569-004 BELSOMRA 20MG TABLET / ORAL RLD, RS 2014-08-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204569-001 BELSOMRA 5MG TABLET / ORAL RLD 2014-08-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204569-002 BELSOMRA 10MG TABLET / ORAL RLD 2014-08-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204569-003 BELSOMRA 15MG TABLET / ORAL RLD 2014-08-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204569-004 BELSOMRA 20MG TABLET / ORAL RLD, RS 2014-08-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204569-001 BELSOMRA 5MG TABLET / ORAL RLD 2014-08-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204569-002 BELSOMRA 10MG TABLET / ORAL RLD 2014-08-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204569-003 BELSOMRA 15MG TABLET / ORAL RLD 2014-08-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204569-004 BELSOMRA 20MG TABLET / ORAL RLD, RS 2014-08-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N204569-001 BELSOMRA 5MG TABLET / ORAL RLD 2014-08-13 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N204569-002 BELSOMRA 10MG TABLET / ORAL RLD 2014-08-13 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N204569-003 BELSOMRA 15MG TABLET / ORAL RLD 2014-08-13 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N204569-004 BELSOMRA 20MG TABLET / ORAL RLD, RS 2014-08-13 d06236e962d9…
Observed Orange Book patent history# Patent history page 1 of 10 · 388 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N204569-001 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-001 10098892 2033-05-29 Drug product 2018-10-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-001 11980623 2033-05-29 Drug product 2024-05-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-002 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-002 10098892 2033-05-29 Drug product 2018-10-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-002 11980623 2033-05-29 Drug product 2024-05-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-003 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-003 10098892 2033-05-29 Drug product 2018-10-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-003 11980623 2033-05-29 Drug product 2024-05-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-004 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-004 10098892 2033-05-29 Drug product 2018-10-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204569-004 11980623 2033-05-29 Drug product 2024-05-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-001 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-001 10098892 2033-05-29 Drug product 2018-10-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-001 11980623 2033-05-29 Drug product 2024-05-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-002 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-002 10098892 2033-05-29 Drug product 2018-10-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-002 11980623 2033-05-29 Drug product 2024-05-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-003 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-003 10098892 2033-05-29 Drug product 2018-10-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-003 11980623 2033-05-29 Drug product 2024-05-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-004 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-004 10098892 2033-05-29 Drug product 2018-10-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204569-004 11980623 2033-05-29 Drug product 2024-05-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N204569-001 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-001 10098892 2033-05-29 Drug product 2018-10-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-001 11980623 2033-05-29 Drug product 2024-05-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-002 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-002 10098892 2033-05-29 Drug product 2018-10-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-002 11980623 2033-05-29 Drug product 2024-05-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-003 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-003 10098892 2033-05-29 Drug product 2018-10-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-003 11980623 2033-05-29 Drug product 2024-05-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-004 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-004 10098892 2033-05-29 Drug product 2018-10-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204569-004 11980623 2033-05-29 Drug product 2024-05-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204569-001 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204569-001 10098892 2033-05-29 Drug product 2018-10-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204569-001 11980623 2033-05-29 Drug product 2024-05-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204569-002 7951797 2029-11-20 U-620 Drug substance, Drug product 2014-09-10 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 96 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 28 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0006-0005 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0005 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0005 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0005 BELSOMRA suvorexant Merck Sharp & Dohme LLC NDA Current 0006-0005 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0005 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0005 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0033 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0033 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0033 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0033 BELSOMRA suvorexant Merck Sharp & Dohme LLC NDA Current 0006-0033 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0033 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0033 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0325 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0325 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0325 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0325 BELSOMRA suvorexant Merck Sharp & Dohme LLC NDA Current 0006-0325 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0325 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0325 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0335 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0335 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0335 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0335 BELSOMRA suvorexant Merck Sharp & Dohme LLC NDA Current 0006-0335 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0335 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current 0006-0335 BELSOMRA suvorexant Merck Sharp & Dohme Corp. NDA Current